NIH Blueprint MedTech Translator
Funds neurological device and therapy translation through milestone-based collaborative agreements.
About
NIH Blueprint MedTech Translator sits under NINDS as part of the NIH Blueprint Consortium. It supports translational work and clinical feasibility studies for therapeutic and diagnostic devices aimed at nervous system and neuromuscular disorders.
The mechanism is UG3/UH3, a milestone-driven cooperative agreement, and the current NOFO is PAR-25-383. The program is open through January 29, 2028, us…
HardwareMedtechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.